|

Home What's new with the AISSGA? Aims and Policies Fact Sheets Personal Biographies Newsletter (dAISy) Diagnosis & Related Conditions National AISSGA Conferences Legal Issues Disclosure Genetic Issues Osteoporosis Management of Infants with Intersex Conditions Intersex Discussed in Medical Papers Fertility / Adoption / Surrogacy / Fostering Hormone Therapy Sexuality & Relationships AIS Men Parent's Page Transgender & Intersex? Recommended Reading AIS / Intersex Links Reccomended Clinicians & Counsellors Contact Us
| |
Click on any of the headings to see the full article. (Where available).
Pediatrics
2002; 110: e32. [Abstract] [Full text] [PDF]
Claude
J. Migeon, Amy B. Wisniewski, Terry R. Brown, John A. Rock, Heino F.L. Meyer-Bahlburg,
John Money, and Gary D. Berkovitz
Available
at: http://www.pediatrics.org/content/vol110/issue3/index.shtml#REVIEW_ARTICLE
The AISSGA was recently asked to review this paper for a television network
preparing a documentary on the treatment of children with intersex
conditions. Here is a copy of my letter:
'Thank you for contacting the AIS Support Group Australia (AISSGA) for a
comment about this study.
The AISSGA is pleased Johns Hopkins is conducting research on the treatment
of children with intersex conditions. Unfortunately, follow-up studies and
research on a number of important issues for those affected by intersex
conditions, such as osteoporosis and hormone replacement therapy, is severely
lacking.
While the AISSGA is pleased this study shows that approximately three out
of four children with intersex conditions are happy with the gender they were
assigned at birth, we support the child's right to physical integrity and are
deeply concerned for those children who are not happy with the gender they
were assigned - particularly if they have undergone irreversible medical
intervention. A failure rate of 25% is not acceptable.
There are also those individuals with intersex conditions that are happy
with the gender they were raised, but still grieve for the bodies they were
born with.
Doctors need to realise that the genitals of children with intersex
conditions are never a medical problem.
The results of the companion study that showed half the participants knew
little about their condition demonstrates the importance of full disclosure.
It also raises doubts as to their ability to comment on the success of their
gender assignment.
The focus on the medical management of children with intersex conditions
should be on: obtaining an accurate diagnosis, providing professional
counselling, peer support, accurate and timely information, permitting the
parents time to reflect on all treatment options available, informing the
child in stages about their condition and seeking their consent for any
medical intervention when they are old enough to make these important
decisions for themselves.
The AISSGA's preferred treatment paradigm is attached to this email. Please
feel free to distribute or quote it.
I hope this information has helped. Thanks once again for the opportunity
to comment about the study.
Best wishes,
Tony Briffa'
 |
Sexual Function in Adult Women with
Complete Androgen Insensitivity Syndrome.
Dr Catherine L Minto, MB ChB, & Miss Sarah Creighton, MD MRCOG.
University College London Hospitals, Department of Obstetrics and Gynaecology,
London WC1E, UK.
BACKGROUND: Women with complete androgen insensitivity syndrome (CAIS) have
always been presented as unequivocally feminine women with normal sexual
function. However they have both physical and psychological factors that might
predispose them to suffer sexual dysfunction, eg: shorter than average vaginas,
an inability to respond to androgens and anxieties or concerns about their
condition, which could impact on self esteem, body image, sensuality and sexual
function.
METHODS: This was a questionnaire study and retrospective hospital notes review,
looking at sexual function in XY females with a diagnosis of CAIS. The
questionnaire comprised details on diagnosis and treatment and a modified sexual
function inventory (GRISS) which provided scores encompassing seven areas of
female sexual function. All respondents were invited for a clinical examination
and all hospital notes were collected and analysed for details of diagnosis and
treatments.
RESULTS: 62 women with a current diagnosis and clinical features compatible with
CAIS completed and returned the questionnaire. 21/62 (34%) were examined. 17/62
(27%) were patients and 45/62 (73%) were recruited through the AISSG (Androgen
Insensitivity Syndrome Support Group). 6/62 (10%) had never been sexually
active, and 2/62 did not complete the sexual function questionnaire, leaving
sexual function data on 54 women. Global mean sexual function scores were worse
than the population average. Mean scores were worst for infrequent sexual
activity, non-communication with partner about sexual activity and difficulty
with vaginal penetration.
CONCLUSIONS: Sexual dysfunction is common in CAIS, most significantly in the
areas of difficulty with vaginal penetration, infrequency and non-communication.
****************************************
|
 |
Long term sexual function in Intersex
Conditions with Ambiguous Genitalia. |
Dr Catherine L Minto, MB ChB, Miss Sarah Creighton, MD
MRCOG & Mr Christopher Woodhouse, FRCS.
University College London Hospitals, Department of Urology and Obstetrics and
Gynaecology, London WC1E, UK.
BACKGROUND: Current management for intersex conditions includes clitoral
reduction surgery for those patients with ambiguous genitalia who are being
raised female. Evaluation of this management is difficult due to the scarcity of
long term outcome data looking at sexual function and other outcomes.
METHODS: This was a questionnaire study combined with a retrospective hospital
notes review. The questionnaire comprised detail on diagnosis and treatment
along with a modified sexual function inventory (GRISS) which provided scores
encompassing seven areas of female sexual function. All hospital notes were
collected and analysed for diagnosis and surgical detail.
All respondents were invited for clinical examination.
RESULTS: 37 intersex women, over 18 years old, all with ambiguous genitalia at
birth or in childhood, completed the questionnaire. 11 were patients, 26 were
recruited through the UK AISSG (Androgen Insensitivity Syndrome Support Group).
16/37 (43%) attended for a clinical examination. 10/37 (29%) had had clitoral
surgery deferred and so had currently not undergone clitoral surgery, of which
1/10 (10%) had never been sexually active. Of the 27/37 (73%) who had undergone
clitoral surgery, 9/27 (33%) had never been sexually active, leaving sexual
function data on 18 subjects who had undergone clitoral surgery and 9 subjects
who have virilised female genitalia and have not undergone clitoral surgery.
Mean global sexual function scores were worse in the group with clitoral
surgery. On looking at orgasm scores alone, the group with clitoral surgery had
scores significantly abnormal for difficulty with orgasm, with 5/18 (28%) having
complete anorgasmia.
CONCLUSIONS: This study shows that clitoral surgery can damage adult sexual
function.
*********************************************
 |
Cosmetic and Anatomical Outcomes Following
Feminising Childhood Surgery for Intersex Conditions. |
Miss Sarah Creighton MD MRCOG, Dr Catherine L Minto MB ChB & Mr Stuart J
Steele FRCOG & FRCS.
Department of Gynaecology, University College London Hospitals, London WC1E,
UK.
BACKGROUND: The immediate aim of feminising genitoplasty in the management of
ambiguous genitalia is to make the cosmetic appearance look as female as
possible. In the long term the vagina must also be adequate for menstruation and
intercourse. There is increasing awareness amongst patients and clinicians that
the outcome of this surgery may be unsatisfactory. This study evaluates the
cosmetic and anatomical outcome of feminising genital surgery.
METHODS: 45 girls were examined under anaesthetic. All had undergone
reconstructive genital surgery in childhood for intersex conditions. The
external cosmetic appearance was evaluated and a recommendation made as to
further intervention. In all cases previous surgical notes were reviewed.
RESULTS: The age range was 7.5-19.5 years (mean 15 years). The cosmetic result
was good or satisfactory in 62% of patients. However, in 98% of patients further
intervention was deemed necessary. Of these, 23% required dilators and 77%
surgery. 60% had undergone one previous procedure. The rest had two or more
prior genital operations and one child had undergone six prior genital
procedures. All patients who had undergone prior vaginoplasty required
further treatment to the vagina.
CONCLUSION: Most children undergoing feminising surgery require further
treatment in puberty and this must be made clear to the parents. Vaginal surgery
should be deferred until puberty unless there is a risk of haematocolpos. The
requirement for clitoral surgery should be carefully considered on an individual
basis.
http://www.baps.org.uk/documents/Intersex%20statement.htm
The distance between Mars and
Venus might be closer than previously thought.
The Scientist 15[15]:18, Jul. 23,
2001
By Bob Beale
By:
Kenneth Kipnis, Ph.D.
Department of Philosophy
University of Hawai`i at Manoa
Honolulu, Hawai`i 96822
Milton Diamond, Ph.D.
Department of Anatomy and Reproductive Biology
Pacific Center for Sex and Society
The John A. Burns School of Medicine
University of Hawai`i at Manoa
Honolulu, Hawai`i 96822
Guidelines for dealing with individuals with 'ambiguous'
genitalia.
By:
Milton
Diamond, Ph.D. &
H.
Keith Sigmundson, M.D.
|